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Mucor racemosus is a saprophytic, dimorphic fungus belonging to the order
Mucorales. The fungus grows as branching, filamentous mycelia in an aerobic
environment, but under anaerobic conditions, in the presence of a fermentable hexose,
the fungus exhibits its budding yeast form. Though Mucor species are usually not
pathogens, several species, including M. racemosus, are among the various
Zygomycetes identified as causing a type of opportunistic fungal disease in humans
called mucormycosis.
The objective of this study was to obtain information regarding the effects of
protein prenylation inhibitors on morphogenesis in M. racemosus. The prenylation
inhibitors used were carvone (250 uJvl), perillaldehyde (250 \M) and farnesyl-protein
transferase inhibitor type m (FPT III) (200 ^iM). We hypothesized that exposure of M.
racemosus to the protein prenylation inhibitors carvone, perillaldehyde, and FPT III
would result in inhibition of spore-to-hyphal and yeast-to-hyphal morphogenesis.
In the spore-to-hyphal studies results showed the inhibitors delayed
morphogenesis by 1 hour in Mucor cells. There was a significant difference in spore-
to-hyphal morphogenesis between control cells and cells treated with the inhibitors in
the earlier hours of incubation (5-7 h). However, as a possible result of cell
metabolism, by the 9th h all cells developed 100 % hyphae.
Following redosing with the inhibitors at the 5th h (start ofgerm tube
emergence) of incubation, germ tube emergence was delayed by an additional hour and
hyphal formation was significantly suppressed in the later hours of incubation (8-10 h).
These results suggested the cells were metabolizing the drugs.
During the yeast-to-hyphal studies, as the percentage of cells with buds
decreased, percent germ tube and hyphal formation increased. These results showed
successful yeast-to-hyphal morphogenesis. Following 24 hours of growth, cells treated
with the inhibitors still contained budding yeast cells compared to the control, which
had no presence ofbudding yeast cells and 100 % hyphal development. Results
showed the inhibitors significantly delayed yeast-to-hyphal morphogenesis.
Spore-to-hyphal and yeast-to-hyphal morphogenesis was delayed by the
prenylation inhibitors as shown by lower percentages ofgerm tubes, weights, and
protein concentration levels in cells treated with the inhibitors compared to the control
samples. The experiments conducted with these protein prenylation inhibitors
provided evidence that with repeated doses, conversion ofM. racemosus to its
pathogenic hyphal form can effectively be delayed and possibly inhibited. Further
studies with these drugs and other compounds should provide more information on the
potential of prenylation inhibitors to be used in the treatment of mucormycosis and
other pathogenic fungal diseases.
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Mucor racemosus is a saprophytic, dimorphic fungus belonging to the order
Mucorales. The fungus causes fruit rot and may occur on the decaying fruiting bodies of
mushrooms and toadstools (Orlowski 1991). M. racemosus is a dimorphic species,
meaning it exhibits two morphological forms. The fungus possesses the ability to grow
either as multipolar, budding yeast or as branching mycelia, depending on the
environmental conditions. M. racemosus grows as branching, filamentous mycelia in an
aerobic environment, but under anaerobic conditions, in the presence of a fermentable
hexose, the fungus exhibits its budding yeast form (Rippon 1982; DiSanto and Logan
1989; Casale et al. 1990; Orlowski 1991). It is also the hyphal form of the fungus that is
associated with disease and pathogenicity (Rippon 1982; Orlowski 1991).
Though Mucor species are usually not pathogens, several species, including M.
racemosus are among the various Zygomycetes identified as causing a type of
opportunistic fungal disease in humans called mucormycosis or more commonly referred
to as zygomycosis (Rippon 1982; Orlowski 1991). The level of severity ranges from a
mild case of dermatitis to a deep systemic invasion of the pulmonary or central nervous
systems through the nasopharnyx (Orlowski 1991; Rippon 1982). The mild cases are
treatable with antibiotics, however, the more serious infection can result in a fatal
outcome to the patient (Rippon 1982; Orlowski 1991).
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All eukaryotic cells, including M. racemosus contain Ras proteins. These proteins
function as transducers and are involved in a variety of signaling events (Waugh et al.
2003; Casaleetal. 1990).
Mucor Ras is involved in cellular development, proliferation, and
morphogenesis (Casale et al. 1990; Roze and Linz 1998; Roze et al. 1999). Ras protein
prenylation is essential in order for these processes to occur naturally. Non-prenylated
Ras proteins result in inactivation of the proteins function (Roze and Linz 1998; Roze et
al. 1999). The enzyme farnesyl protein-transferase (FTase) has become a target for a
novel class of potential anti-cancer chemotherapeutic agents called protein farnesyl-
transferase inhibitors or FTIs (Head and Johnston 2003). These FTIs aid in prevention of
Ras protein prenylation, which in turn inhibits the cellular proliferation of cancerous cells
(Head and Johnston 2003).
Similar to M. racemosus, the dimorphic fungus Candida albicans can cause
opportunistic fungal infections in people with compromised immune systems while in its
filamentous form (i.e., cancer, AIDS) (McGeady et al. 2002). The naturally occurring
monoterpenes, carvone and perillaldehyde delayed the transformation of C. albicans to a
filamentous form. These prenylation inhibitors are potential lead compounds used in the
prevention of C. albicans infection (McGeady et al. 2002). Carvone and perillaldehyde
were introduced into M. racemosus and similar results were expected in terms of
inhibition on spore-to-hyphal and yeast-to-hyphal morphogenesis in the fungus.
Mucor provides a simple and unique cellular model in which to study the
relationship between overall cellular growth rate and differentiation (Paznokas and
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Sypherd 1975; Casale et al. 1990; Roze et al. 1999). The objective was to study and
obtain information on the effects of protein prenylation inhibitors on morphogenesis in
M. racemosus. The protein prenylation inhibitors used were carvone (250 uM),
perillaldehyde (250 uM) and farnesyl-protein transferase inhibitor type III (200 uM)
(FPT III). These inhibitors were expected to inhibit spore-to-hyphal and yeast-to-hyphal
transformation in the fungus.
In studying spore-to-hyphal morphogenesis, Mucor spores were induced to grow
as hyphae in an aerobic environment. The yeast-to-hyphal experiment involved shifting
yeast cells sparged with CO2 to an oxygen filled environment. Cultures were incubated
in the presence of the inhibitors and results were analyzed.
Photomicrographs were taken at critical time points during growth, which
provided physical evidence of morphogenesis in the presence of the inhibitors. Dry and
wet weights were taken in the spore-to-hyphal experiment, which were used to determine
if the inhibitors reduced the formation of hyphae. The Bradford Protein Assay was used




2.1 The Life Cycle ofM. racemosus
M. racemosus undergoes both asexual and sexual phases. Spores are formed
from the reproductive mycelium. The most important and widespread type of asexual
reproduction in Mucorales is spore formation (Inderlied and Sypherd 1978; Sypherd et al.
1979). The asexual life cycle ofMucor species is divided into three stages:
sporangiospore germination, vegetative growth, and sporangiospore formation (Peters
and Sypherd 1979; Sypherd et al. 1979). In sexual reproduction, zygospores, formed
from the hyphal fusion of heterothallic (+ /- mating) or homothallic (same mate: +/+ or -/-
) mating types, germinate to produce a single haploid germ sporangiophore with a
terminal sporangium (Orlowski 1991). During meiosis the zygosporangium germinates
to produce hyphae containing haploid spores.
2.2 The Dimorphism of M. racemosus
Though all Mucor species display a variety of different morphologies associated
with the production of sporangiospores, only those that grow in the form of spherical
budding yeasts are referred to as dimorphic (Rippon 1982; Casale et al. 1990; Orlowski
1991). M. racemosus is a dimorphic species. The fungus can be induced to grow as
multipolar yeast or branching hyphae (Orlowski 1991; Roze and Linz 1998). When
grown under CO2 in the presence of a hexose sugar, budding yeast cells are produced;
whereas an aerobic atmosphere induces growth in the hyphal phase (Rippon 1982;
Casale et al. 1990; Orlowski 1991). Mucor can convert from yeast-to-hyphal form
upon transfer from CO2 to air.
Mucor sporangiopsores are formed under a solid medium in aerobic conditions.
They are elliptical in shape of about 6 x 5 urn (Sypherd et al. 1979). Spores are found
in large numbers inside a sac called a sporangium at the terminus of an aerial hyphae
(sporangiophore) (Genthner and Borgia 1978; Rippon 1982; Orlowski 1991). Mucor
hyphae, Figure 1, initially emerge from the spore cell called germ tubes (Genthner and
Borgia 1978; Peters and Sypherd 1979; Domek and Borgia 1981; Orlowski 1991). A
multinucleate tubular structure called coenocytic hyphae develops from the germ tube
by a process of apical extension. The length and width ofhyphae varies within the
fungus. The cell walls are denser, less fibrous, and less differentiated into layers than
those ofMucor yeasts (Sypherd et al. 1979; Orlowski 1991).
v .*■■
Figure 1: Multinucleate, tubular Mucor hyphae
Mucor yeasts, Figure 2, can grow up to approximately 20 urn in diameter. The
spherical multinucleate cells grow and propagate by the production of multiple buds
(Sypherd et al. 1979; Orlowski 1991). Yeast walls are separated into two distinct





Figure 2: Multipolar, budding Mucor yeast cells
2.3 Protein Prenylation of Ras Proteins
Prenylation is a form of lipid modification in which either a C-15 farnesyl or C-
20 geranylgeranyl group is covalently attached via a thioether linkage to the cysteine
residues of proteins near the carboxy terminus (Voet and Voet 1995; Desnoyers and
Seabra 1998). Prenyl groups seem to play a role in anchoring proteins to cell
membranes, among other functions.
Ras proteins belong to a large super-family of proteins known as "low-molecular
weight G-proteins". These proteins are called "G-proteins" because they bind
guanosine nucleotides, GTP and GDP. When they bind GTP, they are active; and when
they bind the diphosphate form, GDP, they are inactive (Becker et al. 2003). Fungal
Ras proteins are involved in cellular responses to nutrients, stress and cell cycle
progression (Waugh et al. 2002).
Ras proteins generally have a farnesyl group attached, which is critical to the
function of the protein (Moasser et al. 1998; Head and Johnston 2003). The inactive
cytosolic Ras must be farnesylated by the addition of a 15-carbon farnesyl lipid by the
protein farnesyl- protein transferase enzyme (FTase) in order to interact with the inner
leaflet of the plasma membrane.
FTase has become a target for a novel class of potential anti-cancer
chemotherapeutic agents called FTase inhibitors, or FTI's. These FTI's inhibit the
growth of Ras transformed cells (Head and Johnston 2003). They could also
potentially prevent the celluar process ofM. racemosus conversion to the hyphal form.
This is because non-prenylated Ras results in inactivation of the proteins function,
which includes cellular morphogenesis.
2.4 Stating the Problem
M. racemosus represents a simple model of eukaryotic cell development and
morphogenesis. The ability of this fungus to convert to a pathogenic form and result in
development of a possible fatal infection (mucormycosis) makes it important to learn
more about the morphological properties of the fungus.
The goal of this research was to study the morphological properties of the
fungus during transition from spore-to-hyphal and yeast-to-hyphal morphogenesis in the
presence of carvone, perillaldehyde and farnesyl-protein transferase inhibitor type III
(FPT III). Increased knowledge of the effects these inhibitors have on morphogenetic
behavior and fungal growth may lead to the development of compounds for use in the
prevention of fungal disease.
2.5 Protein Prenylation Inhibitors
2.5.1 Monoterpenes: Carvone and Perillaldehyde
The monoterpenes carvone and perillaldehyde, Figure 3, have been shown to
have a variety of anti-proliferative effects in microbial (McGeady et al. 2002), as well
as mammalian cell lines. In high concentrations (5 mM), the carvone and
perillaldehyde caused a significant inhibition of growth in the cellular yeast form of C.
albicans. However, the compounds caused inhibition from the benign yeast to the
pathogenic filamentous form in lower concentrations (125-250 uM). Researchers
concluded that the compounds are potentially useful in the treatment of C. albicans
infection (McGeady et al. 2002).
Figure 3: Molecular structures of carvone and perillaldehyde (McGeady et al.
2002)
2.5.2 Farnesyl-Protein Transferase Inhibitor Type HI: FPT III
FPT III, Figure 4, acts as an inhibitor of protein prenylation, whereby a C-15
farnesyl lipid is inhibited from covalently attaching to the cysteine residue of Ras
proteins. As a result, FPT III inhibitor blocks the expression and processing of the ras
genes of M. racemosus.
FTase-mediated post-translational modification of Ras protein is absolutely necessary




Figure 4: Molecular structure of FPT III (CalBiochem 2004)
2.6 Objective
The many studies conducted on M. racemosus have provided an abundance of
information to apply towards further analysis of this fungus and related fungi. In
attempts to study the effect of carvone, perillaldehyde and farnesyl-protein transferase
inhibitor type III on morphogenesis in M. racemosus, various concentrations of the
prenylation inhibitors were added to Mucor cells. Samples were induced to grow as
hyphae in the presence of O2 or budding yeast cells in the presence of CO2. Growth
inhibition was quantitatively and qualitatively analyzed.
2.7 Hypothesis
Exposure ofM. racemosus to the protein prenylation inhibitors carvone (250
uM), perillaldehyde (250 uM) and farnesyl-protein transferase inhibitor type III (200




3.1.1 Cell Cultures and Media Preparation
M. racemosus (formerly M. lusitanicus) ATCC 1216B was used in all
experiments. The growth medium (YPG ) contained (%, w/v): 0.3 yeast extract (Difco;
Detroit, MI), 1.0 Bactopeptone (Difco), 2.0 glucose (Sigma; St. Louis, MO). A final pH
of 4.5 was achieved with sulfuric acid. YPG agar plates were obtained by adding agar (2
% w/v, Difco).
3.1.2 Plating and Harvesting Mucor cells
One hundred microliters ofM. racemosus cells (original stock culture) were
inoculated onto several YPG plates. Plates were incubated at 30 °C for 3-4 days to allow
spores to grow over the plate. Following the incubation period, spores were collected
from the plates and counted under a compound light microscope with a hemacytometer
grid, which was used to determine the final concentration of sporangiospores.
Sporangiospores were stored in 20 % glycerol at -20°C and were used as the working
stock culture (DiSanto and Logan 1989).
3.1.3 Inhibitors, Solutions and Assays
Carvone and perilladehyde were purchased from Aldrich Chem. Co. (St. Louis,
MO). FPT III was purchased from Calbiochem (San Diego, CA). Dimethyl Sulfoxide
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(DMSO), used as a control vehicle, was purchased from Sigma Chemical Co.
Formaldehyde and glycerol were purchased from Fisher Scientific Co. (Fair Lawn, NJ).
The Spectronic Genesys 5 Spectrophotometer was used to determine absorbance
and measure protein concentration. Reagents used in the Bradford Protein Assay were
purchased from Pierce Chemical Company (Rockford, IL). All cultures were pelleted
using an Eppendorf Centrifuge 5415 C. Pictures were taken using a 35 mm camera
attached to an inverted Nikon Labophot-2 light microscope.
3.2 Experimental Methods
3.2.1 Spore-to-Hyphal Morphogenesis
Mucor sporangiospores (20 ul) from the working stock were inoculated into 2 ml
ofYPG (pH 4.5) inside a 25 ml Erlenmeyer flask at a final density of 1 x 106
sporangiospores/ml. The culture was shaken at 200 rpm and incubated at 30 °C for 9 hr.
Following every hour of growth, 100 ul of cells were collected into a 1.5 ml
microcentrifuge tube and centrifuged for 1 minute. Cells were resuspended in 20 ul of 3.7
% formaldehyde, which acted to fix the cells and prevent further growth. Cells were
stored at 4 °C for later use in determining percent germ tube formation and for photo
imagery. The formula for determining percent germ tubes with cells counted under a light
microscope is shown below (DiSanto and Logan 1989).
Percent germ tubes= # of cells with germ tubes X 100
total # of cells counted
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3.2.2 Spore-to-Hyphal Morphogenesis in the Presence of Inhibitors
Monoterpenes: Mucor spores (1 x 106sporangiospores/ml) from the working
culture were inoculated into 2 ml YPG media containing either DMSO (0.1 %), or
carvone and perillaldehyde at a final concentration of 250 uM in DMSO. Each culture
was shaken at 200 rpm at 30 °C for 9 hr. Following every h, 100 ul of cells were
collected, centrifuged and resuspended in 3.7 % formaldehyde and stored at 4 °C.
Dry and wet weight determinations: Dry and wet weights were taken at the 6'
and 9th hr. of incubation, which marked germ tube emergence and hyphal elongation in
control and drug treated samples. Following each time point, 200 ul samples from each
culture were collected and placed on appropriately labeled pieces of filter paper
(Millipore, 0.45 um). Cells were collected by vacuum filtration and washed with
distilled water to remove excess media. Mycelia were then weighed, which provided the
wet weights. In determining dry weights, the same time points were used. Samples (200
ul) were collected from each culture, wrapped in aluminum foil, and placed in an oven at
50 °C overnight. The next day, cells were weighed.
FPTIII: Mucor spores at a final density of 1 x 106 sporangiospores/ml were
inoculated into YPG media in the presence of distilled water or FPT III (200 uM) in
water. Samples were shaken at 200 rpm at 30 °C for 9 hr. Following every hour, 100
ul of cells were collected, centrifuged and resuspended in 10 ul 3.7 % formaldehyde
for future quantitative analysis and digital imagery. Dry and wet weights were taken at
the 6th and 9th h for both control and treated samples.
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3.2.3 M. racemosus Yeast growth
Mucor yeast cells were obtained by inoculating YPG medium with
sporangiospores to a final density of 2 x 105 sporangiospores/ml. The culture was
shaken and maintained in a partial anaerobic state by sparging CO2 gas into the culture
for 4-6 days. Following yeast growth, percent yeast was determined by the same
method used to determine percent hyphae (see section 3.2.1). The culture was stored at
4 °C and used as the yeast starter culture.
3.2.4 Yeast-to-Hyphal Morphogenesis in the Presence of Inhibitors
Monoterpenes: Mucor yeast cells were inoculated into YPG media in the
presence of carvone (250 uM) or perillaldehyde (250 uM). Cultures were shaken at 200
rpm and incubated at 30 °C for 24 hr.
Following every hour of incubation from 1-8 and the 24l hr., 1 ml of each
sample, in duplicate, was collected and whole cell protein concentrations were
determined. At the same time points, 100 ul of cells were collected and stored at 4 °C
in 10 ul formaldehyde (3.7 %) for photomicrographs and quantitative analysis.
FPTIII: Mucor yeast cells were incubated in the presence of distilled water or
FPT III (200 uM) and were shaken at 200 rpm and 30 °C for 24 hours. After every hour,
from 1-8 and the 24th hr., 1 ml from each sample was collected to determine protein
concentration. At the same time points, 100 ul from each sample was collected and
stored at 4 °C in 10 ul formaldehyde (3.7 %) for photomicrographs and quantitative
analysis.
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Bradford Protein Assay: The Bradford Protein Assay (Bradford 1976) was used
to determine the protein concentration of the yeast starter culture and individual samples
during yeast-to-hyphal morphogenesis in the presence of the inhibitors. During the 24 h
incubation period, whole cell protein concentrations were measured every hour in
duplicate at 595 nm. The procedure included collecting 1 ml from each sample. Cells
were placed in 1.5 ml microcentrifuge tubes. Samples were centrifuged for 1 minute and
washed with 1 ml distilled water. The centrifugation and washing process was repeated.
Cells were resuspended in 25 ul distilled water, solubilized for 15 minutes in 25 ul 1 N
NaOH and neutralized with 50 ul 0.5 N hydrochloric acid. Volumes were raised to 1 ml
by addition of 900 ul distilled water to tubes. Samples were transferred to test tubes and
1 ml of Coomassie blue reagent (Pierce Chemical Co.) was added to each sample and
vortexed. Bovine Serum Albumin, fraction V (BSA) was used as the standard. The




4.1 Effects of Monoterpenes on Spore-to-Hyphal Morphogenesis
Figure 5 shows percent germ tube/hyphae development of cells incubated in the
presence of carvone and perillaldehyde. Control (DMSO) germ tube emergence, 4 %,
occurred between 4 and 5 hours of incubation. At the same time point, cells treated with
carvone and perillaldehyde had not developed germ tubes. Germ tube development was
delayed by 1 hr. in cells treated with the monoterpenes compared to the control (DMSO).
After 6 hours, germ tubes increased to 33 % in control cells compared to 4.1 % and 5.95
% in cells treated with carvone and perillaldehyde, respectively. The largest difference in
germ tube/hyphal development occurred after 7 hours of incubation. Control cells
developed 92 % hyphae, whereas carvone and perilladehyde treated cells developed
11.95 % and 18.35 % germ tubes, respectively. At the 5th, 6th and 7th hr., there were
significant suppressions in the development of germ tubes between control cells and cells
treated with carvone and perillaldehyde (p<0.05).
After the 8th hr. of incubation, cells overcame the effects of the compounds and
reached stationary growth phase. There was 92 % and 98.5 % hyphal cells in carvone
and perillaldehyde samples, respectively, at this phase compared to 100 % in the control
cells. There was no significant difference in germ tube/hyphal development between
control and cells treated with the inhibitors at the 8th hr. of incubation (p>0.05).
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Figure 5: Percent germ tube/hyphae development in control cells versus cells treated with
carvone (250 uM) and perillaldehyde (250 uM). Bars ± represent standard deviation: 5l -
7th h (p<0.05)
4.1.1 Spore-to-Hyphal Morphogenesis Following Redosing with Monoterpenes
Prior to redosing, in the initial experiment, germ tube/hyphal development in
cells treated with the control and the monoterpenes began after 5 and 6 hours of
incubation, respectively, hi both the control and treated cells, between the start of
germination and the 8th h of incubation there was a large increase in the development of
elongated hyphae. Control cells showed a 25-fold increase in hyphal development
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between 5 and 8 hours of incubation. Cells treated with carvone and perillaldehyde
showed a 20-fold increase in the development of hyphae between 6 and 8 hours of
incubation.
At the 5th h of incubation, cells were redosed with equal volumes ofDMSO
(250 uM) and the monoterpenes (250 uM). Following redosing, control cells were
expected to show the same trend in percent germ tube/hyphae as in the initial experiment.
In contrast, a greater suppression of hyphal development was expected in cells treated
with carvone and perillaldehyde.
Figure 6 shows percent germ tube/hyphae results following the redosing
experiment. As expected, the redosed control cells showed a similar pattern in germ tube
and hyphal development compared to the initial experiment (Figure 5). At the 5' h, germ
tube emergence in the initial and redosing experiments occurred at 4 % and 3.5 %,
respectively. The large increase in hyphal development between 5 and 8 hours of
incubation followed the same trend, with a 25-fold increase in hyphal cells, with 100 %
hyphal development after the 8th h of incubation.
Cells treated with carvone and perillaldehyde showed different patterns in hyphal
development between the initial and redosing experiments. Following redosing of
carvone (6.8 %) and perillaldehyde (8 %) germ tube emergence was delayed to the 7th h;
1 h later compared to the initial experiment. After 8 hours of incubation, hyphal
development in carvone (28 %) and perilladehyde (32 %) was 3-fold lower compared to
cells treated with the compounds at the same 8th h in the initial experiment. Significant
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suppression in hyphal development was extended to the 8th and 9th h of incubation and
,th





Figure 6: Redosing: Percent germ tube/hyphae development in control cells versus cells
treated with carvone (250 uM) and perillaldehyde (250 ^M). Bars ± represent standard
deviation: 5th-9th h (p<0.05)
4.2 Spore-to-Hyphae: Digital Imagery of Cells Treated with Monoterpenes
Figures 7-9 show digital imagery of cells treated with DMSO, carvone and
perillaldehyde. After 1 h of incubation, there was no difference in the appearance of
Mucor sporangiospores in control and treated samples (Figures 7-9, panel A). After 5
hours of growth, control cells (4 %) developed germ tubes (Figure 7, panel B). At the
same 5th h, carvone (Figure 8, panel B) and perillaldehyde (Figure 9, panel B) treated
cells contained no germ tubes. Instead, cells appeared large and swollen. Germ tube
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emergence in carvone (4.1 %) and perillaldehyde (5.95 %) treated cells started after the
6th h, of incubation (Figures 8 and 9, panel C). In contrast, control cells (33 %)
developed elongating hyphae (Figure 7, panel C). After 9 hours of incubation, all cells
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Figure 7' Spore-to-hyphal morphogenesis in the presence ofDMSO at A) 1st h (0 %







Figure 8: Spore-to-hyphal morphogenesis in the presence of carvone at A) 1st h (0 %











Figure 9: Spore-to-hyphal morphogenesis in the presence of perillaldehyde at A) 1st h (0
% germ tubes, B) 5th h (0 % germ tubes), C) 6th h (5.95 % germ tubes), D) 9th h (100 %
hyphae) (400X)
4.2.1 Spore-to-Hyphae: Digital imagery of Cells Following Redosing with
Monoterpenes (250 uM)
Figure 10 and 11 show digital imagery of cells treated following redosing of the
monoterpenes after 5 hours of incubation. As shown in percent germ tube/hyphae data,
germ tube emergence was delayed to the 7th h in cells treated with carvone (6.8 %)
(Figure 11, panel A) and perillaldehyde (8 %) (Figure 11, panel D). At the same time
point, germ tubes in the control (31 %) (Figure 10, panel A) were 4-fold greater. In the
initial experiment, control and treated cells developed 100 % hyphae after 9 hours of






















4.3 Spore-to-Hyphae: Dry and Wet Weight of Cells Treated with
Monoterpenes
Dry and wet weight results should provide supporting evidence on percent germ
tube/hyphae data. Hyphae are larger in size than sporangiospores; therefore samples with
greater weights indicated more hyphae present in the sample. Initial dry and wet weights
were compared at the 6th and 9th h, which marked the start of germ tube emergence and
100 % hyphal development in cells treated with the monoterpenes. These values were
compared to dry and wet weights taken at the same phase following redosing with each
compound.
At the 6th h, the initial dry weight for the control sample was 13.8 mg (Figure 12).
At the same 6th h, dry weights for carvone and perilladehyde cells were 1.0 mg and 4.3
mg, respectively. There was a significant difference in the weight of cells between the
control and monoterpenes at the 6th h of incubation (p<0.05). The 9th h initial dry weights
in the control, carvone and perillaldehyde treated cells were 57 mg, 54 mg, and 59 mg,
respectively. There was no significant difference in dry hyphal mass between the control
and cells treated with the compounds at the 9th h (p>0.05).
In the redosing experiment, the dry weight for the control at the 6th h was 13.0
mg, which was close in value to the initial control (13.8 mg) dry weight (Figure 12). In
cells treated with another dose of carvone (250 uM) and perillaldehyde (250 ^iM) the dry
weights at the 6th h were undetectable. As was found in the initial experiment, there was
a significant difference in mass between the control and cells treated with the
monoterpenes (p<0.05). Following 9 h of incubation, dry weights in the control and cells
treated with carvone and perillaldehyde were 59 mg, 33 mg and 37 mg, respectively.
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There was a significant suppression in hyphal formation in cells treated with carvone and
perillaldehyde compared to the control at the 9th h of incubation (p>0.05).
Initial wet weights at the 6th h for control, carvone and perillaldehyde samples
were 20.5 mg, 4.3 mg and 7.3 mg, respectively. Wet weights at the 6th h, Figure 13,
showed there was a significant difference in mass between the control and cells treated
with the monoterpenes (p<0.05). After 9 hours of growth, hyphal mass in the control
increased to 126 mg. The control wet weight was compared to cells treated with carvone
and perillaldehyde at the same 9th h with weights of 129 mg and 128 mg, respectively.
There was no difference in hyphal mass between the control and treated samples (p>0.05)
(Figure 13).
The 6th h control wet weights following re-dosing was 18.5 mg. Cells treated
with the monoterpenes had not yet developed germ tubes, thus there was no detection of
cell material (Figure 13). Following 9 hours of incubation, wet weights reached weights
of 121 mg, 80 mg and 83 mg in the control, carvone and perillaldehyde treated cells,
respectively. There was a significant difference in wet weights between the control and
samples treated with the monoterpenes at the 9th h of incubation (p<0.05).
Results showed there was a greater volume ofhyphae present in control versus
drug treated samples. There was a significant difference in initial dry and wet weights at
the 6th h of incubation, but not so at the 9th h, in control cells compared to cells treated
with carvone and perillaldehyde. However, following re-dosing with the compounds,
there was a significant difference in weights at both the 6th and 9th h between the control
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Figure 12: Initial and redosing dry weights in control cells versus cells treated with










Figure 13: Initial and redosing wet weight in control cells versus cells treated with
carvone (250 uM) and perillaldehyde (250 uM). Bars + represent standard deviation.
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4.4 Effects of FPT III on Spore-to-Hyphal Morphogenesis
As shown in Figure 14, in both control (distilled H2O) and FPT III treated
sporangiospores there was 0 % germ tube emergence in the first 4 h of incubation.
However, by the 5th h of growth, control cells developed 8.5 % germ tubes compared to
0 % in the FPT III treated cells. The first sign of germ tube emergence in FPT III treated
cells occurred after the 6th h of growth at 3.05 %, which was 13-fold less than the 3 % in
the control at the same phase.
After 7 hours of incubation, control cells developed 97 % hyphae compared to 9 %
germ tubes in cells treated with FPT III. This represented a significant difference in the
development of germ tubes in the control compared to FPT III treated cells at the 7th h of
growth (p<0.05). Cells treated with FPT III developed 86 % hyphae versus 100 %
hyphae in the control after 8 hours of incubation. By the 9th h of incubation, cells
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Figure 14: Percent germ tube/hyphae development in control cells versus cells treated
with FPT III (200 [M). Bars ± represent standard deviation. S111^111 h (p<0.05)
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4.4.1 Spore-to-Hyphal Morphogenesis Following Re-Dosing of FPT III
(200 nM)
After 5 hours of incubation, cells were treated with equal doses of the control
and FPT III (200 uM). Percent germ tube/hyphae for the control followed the same
pattern as in the initial experiment. Germ tube emergence occurred at the 5' h of
incubation at 8 % compared to 8.5 % in the initial experiment. There was a large
increase in hyphal formation between 5 and 7 hours of incubation and by the 8th h, 100
% of control cells developed 100 % hyphae.
In cells treated with another dose of FPT III, germ tube emergence was extended
to the 7th h of incubation, at 5 % germ tubes. After 9 hours of growth in the initial
experiment, all FPT III treated cells developed 100 % hyphae. However, following re-
dosing, hyphae development was reduced by half (50 %) at the 9th h of incubation.
Hyphal development in cells treated with FPT III was significantly suppressed between 5
and 10 hours of incubation compared to the control (p<0.05). One hundred percent

















Figure 15: Redosing: Percent germ tube/hyphae development in control cells versus cells
treated with FPT III (200 uM). Bars ± represent standard deviation: 5th-10th h (p<0.05)
4.5 Spore-to-Hyphae: Digital Imagery of Cells Treated with FPT III (200
Photomicrographs were taken at the 6th and 9th h of incubation, which marked
initial germ tube emergence and 100 % hyphal development in cells treated with FPT III,
respectively (Figure 16). The first sign of germ tube emergence in the control (8.5 %)
sample occurred at the 5th h of growth (Figure 16, panel A). At the same time, cells
treated with FPT III (0 %) had not yet developed germ tubes (Figure 16, panel C). Both
control and FPT III treated cells reached 100 % germ tube development by the 9th h of
incubation. As evident, the appearance of cells were the same in both samples at the 9' h





Figure 16: Spore-to-hyphal morphogenesis in the presence ofwater and FPT III at A)
5th h Water (8.5 % germ tubes), B) 9th h Water (100 % hyphae), C) 5th h FPT in,
(3.05 % germ tubes), D) 9th h FPT in (100 % hyphae) (400X)
4.5.1 Spore-to-Hyphae: Digital imagery of Cells Following Redosing with
FPT HI (200 nM)
Figure 17 shows digital imagery of cells following redosing with FPT m and the
control (distilled water). At the 6th h of incubation, 1 h after redosing, control cells
developed 35 % germ tubes. At this time point germ tubes began to extend into hyphae
(Figure 17, panel A). In cells treated with FPT m, there was no indication ofgerm tube
emergence as evident by scattered elliptical-shaped spores in the photomicrograph
(Figure 17, panel D). By the 9th h of incubation, 100 % of control cells developed into a
mass of myceliated hyphae (Figure 17, panel B). In contrast, cells treated with the
inhibitor developed 50 % hyphae, halfthe amount ofthe control (Figure 17, panel E).
As shown in the percent germ tube/hyphae results, cells treated with FPT m developed
100 % hyphae after 11 hours of incubation. At this phase, control and FPT III
treated cells appeared similar in size, shape and mass (Figure 17, panels C and F).
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Figure 17: Re-dosing: Spore-to-hyphal morphogenesis in the presence of FPT III (200
uM) at A) 6th h Water (35 % hyphae), B) 9* h Water (100 % hyphae C) 11th h Water
(100 % hyphae, D) 6th h FPT III (0 % germ tube), E) 9th h FPT III (50 % hyphae, F) 111
h FPT III (100 % hyphae) (400 X)
4.6 Spore-to-Hyphae: Dry and Wet Weights of Cells Treated with FPT III
After the 6th and 9th h of incubation, dry and wet weights were taken for control
and FPT III treated cells (Figures 18 and 19). The dry weight at the 6th h, in control cells,
was 15-fold greater (15.5 mg) compared to cells treated with FPT III (1.1 mg) (Figure
30
18). These results supported the large difference in percent germ tube
development at the same 6l h of incubation. After 9 hours of incubation, both the control
and FPT III treated cells developed 100 % hyphae. Dry weights at this hour are reflective
of the percent
germ tube/hyphae values of the control and FPT III samples with weights at 58 mg and
55 mg, respectively (Figure 18).
After cells were treated with another dose of inhibitor, the rate of germ tube
emergence and hyphal development followed the same pattern as the control sample. At
the 6th h, the control sample weighed 14.0 mg. In contrast, there was no weight detection
in the FPT III sample due to the 0 % germ tube emergence (Figure 18). Following 9
hours, 100 % of control cells developed hyphae with a dry weight of 55 mg. Cells
treated with FPT III developed 50 % hyphae. The dry mass at this hour was
approximately half that of the control at 23 milligrams. (Figure 18)
Figure 19 shows wet weight values in the initial experiment following re-dosing
with the inhibitor. In the initial experiment, the control sample weighed 23 mg compared
to 3.5 mg in the treated sample at the 6th h of incubation. After re-dosing, the control wet
weight remained similar to that of the initial at 19.5 milligrams. There was no detection
ofhyphae in the treatment group at the same hour of incubation. By the 9* h, 100 % of
control cells had developed hyphae with a wet mass of 126 milligrams. In contrast, the
treatment sample showed a mass of 71 milligrams.
In the initial and re-dosing experiment, there was a significant difference in dry
and wet weights at the 6th h in control cells versus cells treated with FPT III (p<0.05).
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There was no significant difference in weights at the 9th h in the initial experiment
(p>0.05). However, following redosing, 100 % hyphal formation was delayed until the
11th h in the treatment group, which resulted in a significant difference in development of
hyphae between the control and cells treated with FPT III (p<0.05).
I Distilled Water
I FPT III
6th h 9th h 6th h: 200 uM 9th h: 200 uM
Figure 18: Initial and re-dosing dry weights of cells treated with the control versus FPT
III. Bars + represent standard deviation.
I Distil led Water
I FPT III
6th h 9th h 6th h: 200 uM 9th h: 200 uM
Figure 19: Initial and re-dosing wet weights of cells treated with the control versus FPT
III. Bars + represent standard deviation.
32
4.7 Yeast-to-Hyphal Morphogenesis in the Presence of Monoterpenes
In studying yeast-to-hyphal morphogenesis in Mucor, yeast cells were shifted
from a partial anaerobic to aerobic environment in the presence of monoterpenes (250
uM). Cells were shaken at 200 rpm at 30 °C for a total of 24 hours. Percent budding
yeast and hyphae were determined every hour of growth (Figures 20 and 21).
4.7.1. Percent Budding Yeast Cells and Germ Tube Development in Cells
Treated with Monoterpenes
In the control and cells treated with the inhibitors, as percent yeast decreased,
percent germ tube formation increased, which indicated successful yeast-to-hyphal
morphogenesis. In cells treated with carvone and perillaldehyde the rate of yeast-to-
hyphal morphogenesis was reduced significantly (p<0.05) (Figures 20 and 21).
Following the first hour of incubation, there was no presence of germ tubes in
any of the cells. However, there was a significant difference in the decline of budding
yeast cells in control cells (46 % budding yeast cells) compared to cells treated with
carvone (59 %) and perillaldehyde (56 %) (p<0.05) (Figure 20).
Cells treated with carvone and perillaldehyde showed first signs of germ tube
emergence after 2.5 hours of incubation at 5 % and 7 % compared to 34 % in control
cells. At this time point, there was a significant difference in germ tube development
between control and drug treated cells (p<0.05) (Figure 21).
By the 6th h of incubation, all yeast cells treated with the control had completely
shed their buds and 100 % of cells developed germ tubes. At the same time, cells treated
with carvone and perillaldehyde only had 35 % and 41 % germ tubes, respectively.
After 24 hours of incubation, 17 % and 14 % of carvone and perillaldehyde treated cells
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contained buds, respectively, compared to 0 % in control cells. During the first 8 hours
and the 24th h of incubation, there was a significant difference in budding yeast cells and
germ tube development between control and monoterpene treated cells (p<0.05).




Figure 20: Percent budding yeast cells treated with carvone and perillaldehyde. (p<0.05)




Figure 21: Percent germ tube/hyphae development in cells treated with carvone and
perillaldehyde. (p<0.05)
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4.8 Yeast-to-Hyphae: Digital Imagery ofYeast Cells Treated with Monoterpenes
In comparing percent budding yeast cells and germ tube/hyphal formation,
photomicrographs show there was a definite difference in appearance of cells between
control and drug treated cells (Figures 22-24). The first sign ofgerm tube emergence in
drug treated cells occurred after 2.5 h of incubation. Carvone and perillaldehyde treated
cells had values of 5 % and 7 % germ tubes, respectively (Figures 23 and 24, panel A).
These percentages were compared to 34 % germ tube, 6-fold greater, in the control cells
at the same hour (Figure 22, panel A).
By the 6th h ofgrowth 100 % of control cells had developed hyphae as evident
in Figure 24, panel B. The value was compared to 35 % and 41 % germ tubes in cells
treated with carvone and perillaldehyde, respectively (Figures 23 and 24, panel B).
After 24 hours ofgrowth, Figure 22, panel C, control cells had developed 100 %
hyphae. Hyphal cells were elongated, and piled into a large mass. Monoterpene treated
cells never reached 100 % hyphae development and after 24 hours ofgrowth, there was
still presence ofbudding yeast cells (Figures 23 and 24, panel C).
Figure 22: Yeast-to-hyphal morphogenesis in the presence ofDMSO at A) 2 h (34 %
germ tubes) B) 6* h (95 % hyphae) and C) 24th h (100 % hyphae) (400X)
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Figure 23: Yeast-to-hyphal morphogenesis in the presence of carvone at A) 2nd h (5 %
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Figure 24: Yeast-to-hyphal morphogenesis in the presence of perillaldehyde at A) 2nd h (7
% germ tubes), B) 6th h (41 % germ tubes), C) 24th h (67 % hyphae) (400X)
4.9 Yeast-to-Hyphae: Protein Concentration of Cells Treated with Monoterpenes
Protein concentration should increase with increased germ tube formation. If the
monoterpenes acted to inhibit yeast-to-hyphal morphogenesis, protein levels should be
lower than in control cells. The results in Figure 21, which showed a significant
suppression in hyphae in cells treated with the inhibitors compared to the control,
paralleled protein concentration levels (Figure 25). After the 4th h of incubation, percent
germ tube development in carvone and perilladehyde treated cells was 18 % and 22 %,
respectively compared to 88 % hyphae in the DMSO treated cells. Protein
concentrations for carvone and perillaldehyde at the same 4th h were 5 jag/ml and 5.5
fig/ml, respectively. DMSO cells had a protein concentration of 15.5 ug /ml, which was
3-fold larger compared to drug treated cells.
By the 8th h, 100 % of control cells had shed their buds and developed elongated
hyphae. Carvone and perillaldehyde treated cells contained 46 % and 49 % germ tubes,
respectively. As expected, protein levels were considerably higher in the control cells
versus drug treated cells at the 8th h. Protein levels at the 8th h were 26 ug/ml, 7.0 ng/ml
and 7.5 |ig/ml in control, carvone and perillaldehyde treated cells, respectively. During
all hours of incubation there was a significant difference in protein concentration of
control versus carvone and perillaldehyde treated Mucor cells (p<0.05) (Figure 25).







Protein concentration (|ag/ml) of cells treated with carvone and perilladehyde.
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4.10 Yeast-to-Hyphal Morphogenesis in the Presence of FPT HI
Figure 26 and 27 show percent budding yeast cells and germ tube/hyphal
formation following an environmental shift ofMucor yeast cells from CO2 to air in the
presence of FPT III.
4.10.1 Percent Budding Yeast and Germ Tube Development of Cells
Treated with FPT III
Following the first hour of incubation, the percentage of budding yeast cells
decreased from 65 % to 42 % in control cells compared to 62 % in cells treated with FPT
III (Figure 26). The first sign of germ tube emergence occurred after the first hour in
control cells with a value of 22 %, versus 11 % germ tubes in cells treated with the
inhibitor (Figure 27). By the 5th h of incubation, 100 % of cells contained hyphae in the
control cells compared to 22 % in cells treated with FPT III (Figure 27). Cells treated
with FPT III never reached 100 % hyphae development. After 24 h of growth, 28 % of
drug treated cells still contained buds.
There was a significant difference in percentage of budding yeast and germ tube
development in cells treated with water compared to FPT III at 1 through 8 hours of
incubation (p<0.05). Therefore, FPT III effectively blocked yeast-to-hyphal
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Figure 26: Percent budding yeast cells treated with FPT III (p<0.05)




Figure 27: Percent germ tube/hyphae development in cells treated with FPT III. (p<0.05)
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4.11 Yeast-to-Hyphae: Digital Imagery of Cells Treated With FPT HI
Figure 28 shows appearance oiMucor cells in the presence of FPT III after 3 and
8 hours of incubation. The 3rd h marked the first appearance of germ tubes in cells
treated with the drug. At this time point, control cells had already reached 80 % hyphal
development with elongated hyphae. As evident, there was a difference in the
appearance of cells at the 3rd h in control versus FPT III treated cells (Figures 28, panels
A and C).
By the 8th h, 100 % of control cells contained hyphae, compared to 50 %, half
the amount, in cells treated with the inhibitor (Figure 28, panels B and D). The
photomicrographs supported percent budding yeast and germ tube/hyphal data, which
showed a decline in budding yeast cells with increased hyphal development.
C. D.
Figure 28: Yeast-to-hyphal morphogenesis in the presence of FPT III at A) Water- 3r h
(80 % hyphae), B) Water- 8th h (100 % germ tubes), C) FPT III- 3rd h (11 % germ tubes,
D) FPT III- 8th h (53 % hyphae) (400X)
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4.12 Yeast-to-Hyphae: Protein Concentration of Cells Treated with FPT III
Figure 29 shows protein concentration values in control and FPT III treated cells.
Following the first hour of incubation protein concentration in the control cells had
increased from 0.75 ug/m to 6.5 |ig/ml. Protein concentration in the FPT III sample, at
the same hour, was 5-fold less at 0.75 to 1.5 ng/ml.
By the 5th h of incubation all cells in the control group had shed all buds and
developed 100 % hyphae. The protein level increased to 22.3 ug/ml. The 5th h in FPT
III treated cells marked 44 % yeast cells and 28 % germ tube formation present. The
protein concentration was 4.8 |ig/ml. At the 8th h, 42 % of drug treated cells developed
germ tubes. The protein concentration increased to 7 ug/ml. At the same hour, control
cells were at 100 % hyphal formation with a protein concentration of 27.5 ug/ml
Overall, there was a significant difference in protein concentration between cells
treated with the control vehicle and those treated with FPT III, (p<0.05), thus FPT III
effectively inhibited yeast-to-hyphal morphogenesis.
■ Distilled Water
•FPT III
Initial 1 2 3 4 5 6
Incubation Time (hrs)
Figure 29: Protein concentration (ug/ml) of yeast cells treated with FPT III. p<0.05.
CHAPTER 5
DISCUSSION
5.1 The Effects of Protein Prenylation Inhibitors on Spore-to-Hyphal
Morphogenesis
The ability ofM. racemosus to convert to a pathogenic hyphal form and result in
the development of a possible fatal infection (mucormycosis) makes it important to
learn more about the morphological properties that govern its process (Rippon, 1982).
In attempts to determine if the protein prenylation inhibitors blocked spore to hyphal
morphogenesis, Mucor spores were incubated for 9 h in the presence of carvone (250
uM) perillaldehyde (250 uM) and farnesyl-protein transferase inhibitor type III (200
uM). Hyphae were detected through percent germ tube/hyphae determination, dry and
wet weights, and photomicrographs.
Wet-harvested spores are released from dormancy when exposed to an aqueous
environment. (DiSanto 1989; Nickerson, et al. 1975). In the first 4 h of incubation cells
in the control and the treatment showed no signs of germ tubes (Figures 5 and 14).
Germ tube emergence began after 5 h of incubation in the control cells (4 %).
However, as expected, in cells treated with carvone (250 uM), perillaldehyde (250 uM)
and FPT III (200 uM) germ tube emergence was delayed to the 6th h of incubation. The
compounds did not inhibit morphogenesis because after 8 hours of incubation the cells
overcame the effects of the inhibitors and developed 100 % hyphae.
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Dry and wet weight results provide supporting evidence on percent germ
tube/hyphae data. Hyphae are larger in size than sporangiospores, (Orlowski 1991;
Sypherd et al. 1979) therefore samples with greater weights indicated more hyphae
present in the sample. Percent hyphal data correlated with results from dry and wet
weight analysis taken at 6 and 9 h of incubation (Figures 12, 13 and 18, 19). At hour 6
there was a large difference in both dry and wet weights between control and drug
treated cells. These findings coincided with the significant difference in hyphal
development after 6 h ofgermination between both groups.
The large increase in hyphae formation between the hours of 5 and 7 were
possibly due to Mucor cells metabolizing the inhibitors. A previous study showed this
same pattern of increase in the formation ofM racemosus hyphal cells (DiSanto 1989).
While there is no information provided on cell metabolism of these inhibitors in M.
racemosus, these compounds were found to be degraded in other fungi and bacteria
(Duetz et al. 2003; Farooq et al. 2002).
To determine if the theory was correct, cells were treated with another dose ofthe
compounds at the 5th h of incubation followed by calculation of percent germ tubes/
hyphal (Figures 5 and 15) and dry and wet weights (Figures 10, 11 and 16, 17). If
suppression was extended to the later hours of incubation, then the inhibitors were
degraded within the cells. If suppression was not prolonged, then its possible the Ras
prenylation pathway was blocked and instead an alternate pathway was switched on
during incubation in the presence ofthe inhibitors.
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Results showed when treated with another dose of the monoterpenes and FPT
III, germ tube emergence was delayed by another hour. Cells treated with carvone and
perillaldehyded showed an extended suppression of hyphal formation up until the 9th h
and 100 % hyphal formation occurred at the 10th h of incubation compared to the 9th h
in the initial experiment. In the sample treated with FPT III, significant hyphal
suppression was prolonged to the 10th h of growth. Cells developed 100 % hyphae after
11 h of incubation. Re-dosing experiments supported the theory that cells metabolized
the inhibitors during the incubation process.
5.2 The Effects of Protein Prenylation Inhibitors on Yeast-to-Hyphal
Morphogenesis
Yeast-to-hyphal results supported the hypothesis that the drugs would have a
significant inhibitory effect on morphogenesis in Mucor. During the 24 h incubation
period, percent germ tube/hypal values were significantly different in control versus
monoterpene and FPT III samples (Figures 21 and 27). Control cells showed 100 %
hyphae formation at the 6th h of incubation. In contrast, cells treated with the inhibitors
still contained budding yeast cells after 24 h of incubation (Figures 23 and 24). During
all hours of incubation, there was a significant difference in the production ofhyphae in
control cells versus cells treated with carvone, perillaldehyde and FPT III (p<0.05).
Results were supported by previous research conducted on yeast-to-hyphal
morphogeneis ofMucor racemosus in the presence ofthe protein synthesis inhibitor
cycloheximide (DiSanto 1988), whereby yeast-to-hyphal morphogenesis was blocked in
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the presence ofthe inhibitor. Research conducted by McGeady et al. 2002, also showed
carvone and perillaldehyde had inhibitory effects on yeast-to-hyphal morphogenesis in
the fungi Candida albicans.
Whole cell protein concentrations were taken to support percent germ tube
results, which showed a significant suppression ofhyphae in the presence ofthe
compounds (Figures 25 and 29). Ifthe inhibitors effectively suppressed the formation
of elongated hyphal cells, protein synthesis should be reduced, thus resulting in lower
protein concentration levels. The results obtained in whole cell protein concentrations
showed there was a significant difference in carvone, perillaldehyde and FPT III treated




The experiments conducted with the protein prenylation inhibitors carvone,
perillaldehyde and FPT III provided evidence that these inhibitors delay the production
of pathogenic hyphal cells inM racemosus. However, the delay is only significant in
the earlier hours (5-7) of incunation. After 8 hours of incubations cells appear to
metaboloize the drugs and continue with the transformation until all cells develop 100
% hyphae.
As evident by re-dosing studies, repeated doses ofthe drugs could result in
further delay and/or complete inhibition in the conversion ofthe fungus to its
pathogenic hyphal form. The introduction ofthese drugs in 2 h intervals up to the 10th h
could result in an even stronger inhibitory effect ofthe morphological process.
Increasing the concentration ofthe drugs also could result in inhibition of hyphal cells.
It is of great importance to further observe the effects ofthese drugs on yeast
growth. If yeast growth is not inhibited it would provide supporting evidence that
morphogenesis, not just growth, was inhinbited by these compounds. Further studies
conducted on the effects of these drugs and other compounds should provide more
information on the potential ofprenylation inhibitors to be used in the treatment of
mucormycosis and other pathogenic fungal diseases
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